We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A preliminary study found that rhBMP-7 ...

(HealthDay News) — Patients receiving high-dose recombinant human bone morphogenetic protein-2 (rhBMP-2) as part of spine surgery have an increased risk of cancer and may be at risk for major ...

Adding to previous evidence, a study based on a statewide cancer database shows no increase in cancer risk in patients undergoing spinal fusion surgery with the bone-promoting growth factor ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Using rhBMP-2 along with adequate stabilization yields ...

Recombinant bone morphogenetic protein-2 (rhBMP-2, Medtronic Inc), used to promote bone growth in spinal fusion surgery, offers little or no benefit over bone graft and may be associated with more ...

Adding to previous evidence, a study based on a statewide cancer database shows no increase in cancer risk in patients undergoing spinal fusion surgery with the bone-promoting growth factor ...

July 2, 2008 — Life-threatening complications have been reported with off-label use of bone morphogenetic protein (rhBMP) in cervical spine fusion, the US Food and Drug Administration (FDA) warned ...

Embarking on a successful journey of exporting its home-grown product technology to North America, the largest market for bone substitutes Enabling fast bone formation by applying bone morphogenetic ...

Self-Management of Low Back Pain Has Small Effects For patients with lumbar spondylosis or spondylolisthesis of the lowest lumbar levels who undergo open anterior lumbar interbody fusion (ALIF), use ...

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced a strategic partnership agreement with ...